Dr. John Maddox, Trauma Medical Director, and Dr. Gregory Chesnut, Center for Prostate Disease Research of the Murtha Cancer Center Director, at Walter Reed National Military Medical Center, Bethesda, Maryland, provided the following statement today regarding Secretary of Defense Lloyd J. Austin III's medical care:
As part of Secretary Austin's routinely recommended health screening, he has undergone regular prostate specific antigen (PSA) surveillance. Changes in his laboratory evaluation in early December 2023 identified prostate cancer which required treatment. On December 22, 2023, after consultation with his medical team, he was admitted to Walter Reed National Military Medical Center and underwent a minimally invasive surgical procedure called a prostatectomy to treat and cure prostate cancer. He was under general anesthesia during this procedure. Secretary Austin recovered uneventfully from his surgery and returned home the next morning. His prostate cancer was detected early, and his prognosis is excellent.
On January 1st, 2024, Secretary Austin was admitted to Walter Reed National Military Medical Center with complications from the December 22 procedure, including nausea with severe abdominal, hip, and leg pain. Initial evaluation revealed a urinary tract infection. On January 2, the decision was made to transfer him to the ICU for close monitoring and a higher level of care. Further evaluation revealed abdominal fluid collections impairing the function of his small intestines. This resulted in the back up of his intestinal contents which was treated by placing a tube through his nose to drain his stomach. The abdominal fluid collections were drained by non-surgical drain placement. He has progressed steadily throughout his stay. His infection has cleared. He continues to make progress and we anticipate a full recovery although this can be a slow process. During this stay, Secretary Austin never lost consciousness and never underwent general anesthesia.
Prostate cancer is the most common cause of cancer among American men, and it impacts 1 in every 8 men – and 1 in every 6 African American men - during their lifetime. Despite the frequency of prostate cancer, discussions about screening, treatment, and support are often deeply personal and private ones. Early screening is important for detection and treatment of prostate cancer and people should talk to their doctors to see what screening is appropriate for them.
